Founded in 2017 and headquartered in Houston, United States, RETINA-AI Health, Inc. specializes in creating artificial intelligence-driven solutions for diabetic retinopathy detection and patient health monitoring.
Subscribe to see RETINA-AI Health, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
RETINA-AI Health, Inc. is a healthtech company headquartered in Houston, United States. Its most recent funding round raised $2.5M in April 2022. Xcout tracks 2 named people at RETINA-AI Health, Inc., including Dr. Stephen G. Odaibo (Founder, CEO, and Chief Data Engineer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.5M | — | |
| Series A | $2.6M | 1 named | |
| SEC Form D filing | $4.6M | — | |
| Series A | $5.2M | 10 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of RETINA-AI Health, Inc.'s closest competitors — see the full list of competitors and alternatives →
AEYE Health provides FDA-cleared, autonomous artificial intelligence solutions for diagnostic screening, specializing in instant diabetic retinopathy diagnosis using handheld and tabletop retinal cameras. The company serves primary care physicians, endocrinologists, and teleretinal screening providers by enabling on-the-spot diagnoses that eliminate the need for specialist referrals.
Ainnova Tech is a health technology company that provides an artificial intelligence platform called VisionAi for early disease detection using retinal scans. Its software detects diabetic retinopathy, cardiovascular risk, type 2 diabetes risk, liver fibrosis, and chronic kidney disease progression to help healthcare providers prevent complications and blindness.
Optain Health, Inc. is a healthcare technology company founded in 2023 and headquartered in New York City. The company utilizes artificial intelligence, robotic retinal imaging, and teleophthalmology to provide non-invasive screening and early detection of systemic and chronic diseases.
AI Optics, Inc. implements handheld imaging technology that integrates artificial intelligence to provide a new standard of care for disease screening. Headquartered in New York, the company focuses on healthcare innovations and disease identification.
Riverain Technologies, Inc., also doing business as Riverain Medical, is a small disadvantaged business headquartered in the United States that specializes in advanced artificial intelligence healthcare solutions.
DeepRadiology Corp develops artificial intelligence and deep learning algorithms to analyze medical imaging modalities such as CT scans, X-rays, and mammography. The company serves healthcare facilities, including hospitals, trauma centers, and outpatient imaging centers, to optimize their diagnostic services.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about RETINA-AI Health, Inc.? Suggest a correction · Work at RETINA-AI Health, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.